News in Numbers

17.3% 

The telehospital sector is forecast to witness 17.3% growth rate till 2027, fueled by a growing number of government initiatives encouraging the use of virtual consultation.

£2.1bn 

The UK Government has committed £2.1bn to fund NHS IT upgrades and digital health technology as part of the nations 2021 budget announcement.

10 

An international regulatory collaboration between the US, UK and Canada has identified and co-published ten guiding principles that should be addressed when medical devices use artificial intelligence or machine learning software.

28 million 

NHS login, the UK digital service that supports the NHS App, has accumulated almost 28 million users – up from around 2.2 million in September 2020, according to the latest statistics from NHS Digital.

45%

New research assessing patient satisfaction and preferences for telemedicine, found that 45% of people with cancer preferred telemedicine over in-person appointments.

  Top Stories 

Roche launches comprehensive genomic profiling kit

The AVENIO Tumor Tissue Comprehensive Genomic Profiling Kit is the first jointly-developed product that brings together the expertise and reach of Roche with Foundation Medicine’s pioneering leadership in genomic science.

Source: Roche

Patients Must Be Warned of Breast Implant Risks, FDA Says

A decade after scientists identified a link between certain implants and cancer, the US Food and Drug Administration (FDA) has ordered “black box” warnings and a new checklist of risks for patients to review.

Source: New York Times

Carbon nanotube-based sensor can detect SARS-CoV-2 proteins

Researchers from the Massachusetts Institute of Technology (MIT) in the US have developed a new sensor to detect SARS-CoV-2 proteins without antibodies. The new sensor eliminates the need to send the sample to a lab for analysis using antibodies or other reagents and provides results within five minutes.

Source: MIT

Genentech’s new treatment for wet AMD receives FDA approval

Genentech has received approval from the US FDA for Susvimo, the first wet, or neovascular, AMD treatment in 15 years to provide an alternative to standard-of-care eye injections needed as often as once a month.

Source: Optometry Times

Embracing Emerging Technologies 

Medable

Medable’s platform was designed to solve the systemic challenges inherent in modern clinical trials including access, interoperability between systems, and inefficient and frustrating technology experiences.

Source: Medable

Reperio Health

The Reperio kit pairs with our smartphone app to guide you through your biometric screening, providing a solid understanding of your health in under an hour.

Source: Reperio Health

Mnemo

Biotechnology company Mnemo uses its EnfiniT platform, an integrated drug discovery engine to develop cell therapies.

Source: Mnemo

Nines

US-based company Nines is a tele-radiology and artificial intelligence startup. Its product NinesAI is FDA-cleared to triage time-critical, life-threatening indications of mass effect and intracranial hemorrhage.

Source: Nines

Lucira Health

Biotechnology company Lucira Health offers disposable at-home test kits to detect infectious diseases, such as Covid-19.

Source: Lucira Health

Bloomlife

US-based company Bloomlife is using technology, data science and medical expertise to address issues in maternal health.

Source: Bloomlife